HOUSTON, April 19, 2018 -- Sharps Compliance Corp. (Nasdaq:SMED) announced today that it will release its third quarter results for the period ended March 31, 2018, before the opening of the financial markets on Wednesday, April 25, 2018. A conference call and webcast will follow at 11:00 a.m. ET, in which management will discuss the Company’s financial results, key market initiatives and business strategy.
The Sharps conference call can be accessed by domestic callers by dialing (877) 407-0782. International callers may access the call by dialing (201) 689-8567. The webcast can be monitored at www.sharpsinc.com.
A telephonic replay will be available through May 25, 2018. To listen to the replay, domestic callers should dial (877) 481-4010 and international callers should dial (919) 882-2331 and enter replay ID number 28129. Transcript will also be posted to the Sharps website, once available.
About Sharps Compliance Corp.
Headquartered in Houston, Texas, Sharps Compliance is a leading full-service national provider of comprehensive waste management services including medical, pharmaceutical and hazardous. Its key markets include healthcare facilities, pharmaceutical manufacturers, home healthcare providers, assisted living / long-term care, surgery centers, retail pharmacies and clinics, and the professional market which is comprised of physicians, dentists and veterinary practices. The Company's flagship product, the Sharps Recovery System, is a comprehensive solution for the containment, transportation, treatment and tracking of medical waste and other used healthcare materials. The Company also offers its route-based pick-up service in a twenty-three (23) state region of the South, Southeast and Northeast portions of the United States.
More information on the Company and its products can be found on its website at: www.sharpsinc.com
Safe Harbor Statement
The information made available in this news release contains certain forward-looking statements which reflect Sharps Compliance Corp.'s current view of future events and financial performance. Wherever used, the words "estimate," "expect," "plan," "anticipate," "believe," "may" and similar expressions identify forward-looking statements. Any such forward-looking statements are subject to risks and uncertainties and the company's future results of operations could differ materially from historical results or current expectations. Some of these risks include, without limitation, the company's ability to educate its customers, development of public awareness programs to educate the identified consumer, customer preferences, the Company's ability to scale the business and manage its growth, the degree of success the Company has at gaining more large customer contracts, managing regulatory compliance and/or other factors that may be described in the company's annual report on Form 10-K, quarterly reports on Form 10-Q and/or other filings with the Securities and Exchange Commission. Future economic and industry trends that could potentially impact revenue and profitability are difficult to predict. The Company assumes no obligation to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results, express or implied therein, will not be realized.
| Company Contact: | Diana Diaz |
| Sharps Compliance Corp. | |
| Email: [email protected] | |
| Office: (713) 660-3547 | |
| Investor Contact: | John Nesbett/Jennifer Belodeau |
| Institutional Marketing Services | |
| Email: [email protected] | |
| Office: (203) 972-9200 |


Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
FTC Questions Apple News Over Alleged Bias Against Conservative Media
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Vietnam Approves SpaceX Starlink Satellite Internet Service Amid U.S. Trade Talks
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal 



